Vcanbio Cell & Gene Engineering Corp., Ltd
Vcanbio Cell & Gene Engineering Corp., Ltd
Aktie · CNE000000545 (XSHG)
Übersicht
Kein Kurs
Schlusskurs XSHG 29.10.2025: 23,82 CNY
29.10.2025 07:00
Aktuelle Kurse von Vcanbio Cell & Gene Engineering Corp., Ltd
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XSHG: SSE
SSE
600645.SS
CNY
29.10.2025 07:00
23,82 CNY
0,02 CNY
+0,08 %
Free Float & Liquidität
Free Float 75,02 %
Shares Float 342 M
Ausstehende Aktien 455,9 M
Firmenprofil zu Vcanbio Cell & Gene Engineering Corp., Ltd Aktie
Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, primarily engages in the preparation and storage of cell tests in the People's Republic of China. The company provides cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental sub totipotent stem cells, immune cells, adipose stem cells, and dental stem cells. It also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, safe medication guide gene testing for children and adults, disease genetic testing, disease susceptibility gene testing, etc.; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products. In addition, the company is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and experimental synthetic agents; and in vitro diagnostic reagents and medical devices. Vcanbio Cell & Gene Engineering Corp., Ltd was founded in 1992 and is based in Tianjin, the People's Republic of China.
Erhalte tagesaktuelle Insights vom finAgent über Vcanbio Cell & Gene Engineering Corp., Ltd

Unternehmensdaten

Name Vcanbio Cell & Gene Engineering Corp., Ltd
Firma Vcanbio Cell & Gene Engineering Corp., Ltd
Website https://www.vcanbio.com
Heimatbörse XSHG SSE
ISIN CNE000000545
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Hongqi Wang
Marktkapitalisierung 12 Mrd.
Land China
Währung CNY
Mitarbeiter 2,2 T
Adresse Huayuan Industrial Park, 300384 Tianjin
IPO Datum 1993-05-04

Ticker Symbole

Name Symbol
SSE 600645.SS
Weitere Aktien
Investoren, die Vcanbio Cell & Gene Engineering Corp., Ltd halten, haben auch folgende Aktien im Depot:
PEMBROKE VCT PLC - B ORD 1P
PEMBROKE VCT PLC - B ORD 1P Aktie
TEEKAY CORP
TEEKAY CORP Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025